PUBLISHER: IMARC | PRODUCT CODE: 1423228
PUBLISHER: IMARC | PRODUCT CODE: 1423228
The global dermal facial fillers market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032.
A dermal facial filler is an injectable solution which fills the soft tissue present under the skin. Dermal fillers can be both synthetic and natural. With age, the flexibility of the skin is lost along with the natural hydration which helps in shaping, supporting and adding volume to the face. This phenomenon results in the occurrence of wrinkles and sagging of the skin. Dermal fillers are applied through tiny facial injections to specific areas of the face. They raise and pump the facial skin in a gentle manner by replacing the collagen lost due to the above factors. Dermal fillers are helpful in enhancing the appearance of aging, wrinkling and sagging skin. They are used in the form of a non-invasive treatment to rejuvenate facial skin by minimising or removing wrinkles, raising depressions caused by scars, augmenting lips, and replacing the lost soft-tissue through facial injections.
The dermal facial fillers market is strongly being driven by an increase in the number of people seeking treatment for facial wrinkles and scarring. This increase has occurred on account of a continuous rise in an imbalance diet, stress and insomnia. Another major driver of this market is the fact that this treatment is non-invasive and has does not take a long period of time to be conducted. Moreover, there has been a decrease in the number of complexities which occur post-surgery. In addition to this, the surgery does not have a prominent scarring as it requires very small incisions which has positively influenced the overall growth of the market. Other factors that are catalysing the growth of this market include a rising ageing population, increasing disposable incomes and raising awareness through social media platforms such as youtube and Instagram.
IMARC Group provides an analysis of the key trends in each sub-segment of the global dermal facial fillers market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on material type and product origin.
Temporary Fillers
Collagen
HA
Collagen Stimulators
Semi-Permanent Fillers
CaHa
Permanent Fillers
PMMA
PAAG
Based on the material type, the market has been segmented into temporary fillers, semi-permanent fillers and permanent fillers. Currently, temporary fillers dominate the market, holding the largest share.
Natural
Synthetic
Based on the product origin, the market has been segmented into natural and synthetic.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been examined with some of the key players being Allergan Inc., Galderma S.A., Merz Pharma GmbH & Co. KGaA, AQTIS Medical BV (Sinclair Pharma Ltd.), Bioha Laboratories, Cynosure Inc., Cosmoderm Sdn Bhd (Vanity Cosmeceutical Sdn Bhd), ColBar LifeScience Ltd., Hangzhou Techderm Biological Products Co., Regenerative Medical System, Suneva Medical Inc., Sanofi S.A., SciVision Biotech Inc., Speciality European Pharma Limited (Contura International Ltd.), Syneron Medical Ltd. (Candela Laser Corporation), Ulthera Inc., Visionmed Ltd.
This report provides a deep insight into the global dermal facial fillers market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the dermal facial fillers market in any manner.